98%
921
2 minutes
20
Previous work has shown that distinct Ca(2+) gradients precede and predict the loci of germination of the zygotes of the brown alga, Silvetia compressa (J. Agardh) E. Serrão, T.O. Cho, S.M. Boo et Brawley, that are polarized by unilateral blue light. We show here that dark-grown S. compressa zygotes also form cytosolic Ca(2+) gradients prior to germination and then germinate from the site of elevated Ca(2+). In no case did germination occur without a prior formation of a Ca(2+) gradient. Using the self-referencing Ca(2+)-selective probe, we measured highly localized influx of Ca(2+) during photopolarization, indicating that extracellular stores supply at least some of the Ca(2+) needed to construct a gradient. Finally, we find that germination was inhibited by a bath-applied inhibitor of calcium/calmodulin-dependent kinase II (CaM kinase II), KN-93 (but not by its inactive analog, KN-92), and by an injected inhibitory peptide for the kinase. KN-93 did not interfere with the photopolarization of the zygotes, consistent with the view that calmodulin is not involved in the initial response to light. The KN-93 results indicate that the requirement for active CaM kinase II for germination ends about 2 h before overt germination. We conclude that Ca(2+) gradients, generated in part by localized calcium entry from the seawater, are an essential part of the process of polarity development and expression in these cells, regardless of the nature of the external cue that directs the orientation of the axis. Calmodulin and CaM kinase II are involved in interpreting (but not in establishing) the calcium gradient, allowing germination to occur at the site of elevated calcium, but CaM kinase II appears not to be involved in the initiation of germination.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00425-003-1012-9 | DOI Listing |
Ageing Res Rev
September 2025
Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, 110122, China; Laboratory of Naturel Medicine for drug discovery, School of Pharmacy, China Medical University, Shenyang, 110122, China. Electronic address:
Calcium (Ca)/calmodulin (CaM)-dependent protein kinase II (CaMKII) is an emerging drug target for age-related diseases. It is a multifunctional kinase with complex activation modes, numerous isoforms, broad tissue distribution, and a dual role in health and disease. In particular, its isoforms share a high degree of conservation within the catalytic and regulatory domains, with only minor differences confined to the linker region.
View Article and Find Full Text PDFJ Biol Chem
August 2025
Division of Chemical Biology and Medicinal Chemistry, The University of Texas, Austin, TX, 78712; Interdisciplinary Life Sciences Graduate Program, The University of Texas, Austin, TX, 78712. Electronic address:
Eukaryotic elongation factor-2 kinase (eEF-2K), a member of the α-kinase family, modulates translational rates by phosphorylating eEF-2, a GTPase that facilitates the translocation of the nascent chain on the ribosome during the elongation phase of protein synthesis. eEF-2K is regulated by diverse cellular cues, many of which sensitize it to the Ca-effector protein calmodulin (CaM). CaM, which binds and allosterically activates eEF-2K in the presence of Ca, contains two structural "lobes," each with a pair of Ca-binding EF-hands.
View Article and Find Full Text PDFBiomolecules
August 2025
Department of Biology, University of Toronto Mississauga, Mississauga, ON L5L 1C6, Canada.
Tauopathies are a diverse group of neurodegenerative diseases characterized by the presence of Tau inclusions in neurons and glia. Rather than the classic steps in the transformation of Tau into neurofibrillary tangles, as first studied in Alzheimer's disease, studies on tauopathies reveal the presence of diverse Tau aggregates that appear to be disease-specific. Regardless, the phosphorylation and hyperphosphorylation of Tau, involving various kinases and phosphatases, appear to be central to all tauopathies.
View Article and Find Full Text PDFNat Commun
August 2025
Department of Pathology, University of Cambridge, Cambridge, UK.
DNA replication stress is a hallmark of cancer that is exploited by chemotherapies. Current assays for replication stress have low throughput and poor resolution whilst being unable to map the movement of replication forks genome-wide. We present a new method that uses nanopore sequencing and artificial intelligence to map forks and measure their rates of movement and stalling in melanoma and colon cancer cells treated with chemotherapies.
View Article and Find Full Text PDFColloids Surf B Biointerfaces
December 2025
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, (NIPER), Hyderabad, Telangana 500037, India. Electronic address:
Pazopanib (PZ) is an oral tyrosine kinase inhibitor and the first line of treatment for patients with renal cell carcinoma. The low solubility, poor bioavailability, and high hepatotoxicity of PZ hamper its potential use. The present research aims to improve the bioavailability and reduce hepatotoxicity of PZ by fabricating a co-amorphous system (CAM) using naringin (NGN) to form Pazopanib Naringin Co-amorphous system (PZ-NGN-CAM).
View Article and Find Full Text PDF